(Total Views: 400)
Posted On: 07/28/2021 4:35:55 PM
Post# of 35

$ARCT News Article - Arcturus Announces Regulatory Approval to Proceed with Phase 2 Study of ARCT-810 mRNA Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency https://marketwirenews.com/news-releases/arct...25589.html


My Twitter: WhyteStocks